オンコリスバイオファーマ(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4588/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2016/05/13 | 日証協 | 673,705株 | -6.26% | 137,000株 | +6750% | 511,604株 | -1.19% | 96,660株 | +286.64% |
2016/05/06 | 日証協 | 718,705株 | -0.17% | 2,000株 | -66.67% | 517,744株 | +2.62% | 25,000株 | +706.45% |
2016/04/28 | 日証協 | 719,905株 | -0.24% | 6,000株 | -85.88% | 504,544株 | +0.06% | 3,100株 | -87.08% |
2016/04/22 | 日証協 | 721,605株 | +14.01% | 42,500株 | +16.12% | 504,244株 | +17.01% | 24,000株 | +133.01% |
2016/04/15 | 日証協 | 632,930株 | -11.32% | 36,600株 | +13.21% | 430,958株 | -15.67% | 10,300株 | -41.48% |
2016/04/08 | 日証協 | 713,735株 | +3.3% | 32,330株 | -41.33% | 511,058株 | +2.71% | 17,600株 | +23.94% |
2016/04/01 | 日証協 | 690,905株 | +0.35% | 55,105株 | +199.48% | 497,558株 | +0.49% | 14,200株 | +102.8% |
2016/03/25 | 日証協 | 688,505株 | +1.5% | 18,400株 | -34.98% | 495,156株 | +1.12% | 7,002株 | -48.89% |
2016/03/18 | 日証協 | 678,305株 | +2.69% | 28,300株 | +52.97% | 489,656株 | +2.36% | 13,700株 | -56.51% |
2016/03/11 | 日証協 | 660,505株 | +0.81% | 18,500株 | +362.5% | 478,356株 | +3.62% | 31,500株 | +751.35% |
2016/03/04 | 日証協 | 655,205株 | +8.28% | 4,000株 | -55.56% | 461,656株 | +14.4% | 3,700株 | -45.59% |
2016/02/26 | 日証協 | 605,100株 | -12.23% | 9,000株 | -54.31% | 403,556株 | -16.04% | 6,800株 | -67.15% |
2016/02/19 | 日証協 | 689,405株 | +2.09% | 19,700株 | -66.89% | 480,656株 | +2.6% | 20,700株 | +143.53% |
2016/02/12 | 日証協 | 675,305株 | +0.69% | 59,505株 | +417.43% | 468,456株 | -0.68% | 8,500株 | -30.33% |
2016/02/05 | 日証協 | 670,705株 | +12.16% | 11,500株 | -81.48% | 471,656株 | +16.36% | 12,200株 | -22.29% |
2016/01/29 | 日証協 | 598,000株 | -22.6% | 62,105株 | +37.4% | 405,356株 | -20.76% | 15,700株 | -35.66% |
2016/01/22 | 日証協 | 772,605株 | +0.23% | 45,200株 | -56.16% | 511,556株 | +1.03% | 24,400株 | -3.17% |
2016/01/15 | 日証協 | 770,805株 | +2.17% | 103,105株 | +71.26% | 506,356株 | +3.07% | 25,200株 | +240.54% |
2016/01/08 | 日証協 | 754,405株 | +6.24% | 60,205株 | +671.86% | 491,256株 | +12.76% | 7,400株 | -51.01% |
※株式分割は考慮していませんのでご注意ください。
Page Top